Characterization of Carbapenem-Resistant Gram-Negative Organisms from Clinical Specimens in Yola, Nigeria.
The aim of this study was to identify carbapenem-resistant gram-negative bacteria from clinical specimens of patients in Yola, Nigeria. Routine clinical specimens were screened for the presence of carbapenem-resistant gram-negative bacteria using chromogenic agar plates. Susceptibility of all presumptive isolates to carbapenems was tested by minimum inhibitory concentration and disk diffusion methods. Real time polymerase chain reaction was used to test for presence of carbapenemase genes. Screening of 1741 clinical specimens yielded 119 (6.8%) presumptive carbapenem resistant gram-negative bacteria. Antimicrobial susceptibility testing confirmed carbapenem resistance among 105 of these isolates. New Delhi metallo-beta lactamase (blaNDM) gene was detected in 26 isolates and Verona integron-encoded metallo-beta lactamase (blaVIM) gene was detected in four. The mechanism of resistance could not be identified in approximately two thirds of the carbapenem-resistant isolates. While blaNDM and blaVIM accounted for 28.6% of the resistance seen, further molecular based studies are needed to characterize the other mechanisms of carbapenem resistance in our isolates.